Relivion MG
Commercial- Indications
- Migraine
Company intelligence / Profile preview
Neurolief
Netanya, n/a, Israelneurolief.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Neurolief’s Relivion® platform is FDA-cleared and CE-marked for acute migraine treatment. Clinical trials show significant efficacy over placebo with high rates of complete symptom freedom. For major depressive disorder—including treatment-resistant cases—the pivotal MOOD trial demonstrated statistically significant reductions in depression severity, high remission rates, excellent safety/tolerability profile, and strong patient adherence. The company is preparing regulatory submissions based on these results to expand indications to MDD/TRD[4][6].
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- DeviceNon-pharmacological therapyDigital therapeutics platform (wearable neuromodulation system)
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Sawai Group Holdings Co., Ltd.: Strategic equity investment; exclusive development/marketing agreement for Japan[3].NeuroFront Therapeutics Limited/Pivotal BioVentures China Fund L.P.: Exclusive licensing agreement covering Greater China & South Korea[5].Academic collaborations with leading medical centers in the US & Israel as clinical sites.
Beyond the preview
Go deeper on Neurolief.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Neurolief.